Michael Steinmetz, MD

Appointed
2007

Education & Fellowships

Fellowship - University of Wisconsin Hospital and Clinics
Spine surgery
Madison, WI
2006

Residency - Cleveland Clinic
Neurosurgery
Cleveland, OH
2005

Internship - University of New Mexico School of Medicine
General Surgery
Albuquerque, NM
1999

Medical Education - Texas Tech University School of Medicine
MD
Lubbock, TX
1998

Undergraduate - New Mexico State University
Microbiology
Las Cruces, NM
1994

Professional Highlights

• He has published greater than 145 articles in leading medical journals, is co-author of the text, Anatomical Basis of Neurologic Disease (2009), with a 2nd Edition currently under revision, and is co-editor of Benzel’s Spine Surgery.  He has also served as editor for three additional textbooks, sits on a number of editorial boards, and is a reviewer for several neurosurgery journals, as well as Section Editor for World Neurosurgery, a member of the editorial board for Journal of Neurosurgery-Spine and Deputy editor of The Spine Journal.  He has contributed more than 60 Chapters to the body of surgical spine care literature, with several more in progress.

  Dr. Steinmetz is actively involved in the various professional societies of neurosurgery and spine surgery.  Serving in multiple roles in the Congress of Neurological Surgeons since his early years of training, he is now a member of the CNS Nominating Committee, and Education Committee.  A member of the Executive Committee and Scientific Planning Committee of the CNS/American Association of Neurological Surgeons (AANS) Joint Section on Diseases of the Spine & Peripheral Nerves since 2007, he is also Chairman of their Exhibits Committee.   He s a member of the Minimally Invasive, CME, Governance, Advocacy and the PAC committees for the North American Spine Society.

Certifications

• Neurological Surgery

Specialty Interests

cervical spondylosis, chiari malformation, complex spine instrumentation, degenerative spine disease, spinal cord tumors, Spine Tumors

Memberships

• Congress of Neurological Surgeons
• American Association of Neurological Surgeons
• North American Spine Society
• Society for Neurosciences

See publications for Michael Steinmetz, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 11/4/2024, Dr. Steinmetz has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Steinmetz receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:

• Globus Medical, Inc.

Royalty Payments. Dr. Steinmetz receives or has the right to receive royalty payments for inventions or discoveries commercialized through the companies shown below:

• Globus Medical, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.